SCHEMBL32688183

SCHEMBL32688183

CN(C)CCNC(=O)c1cccc(-c2cc(=O)[nH]c(SCc3nnn[nH]3)c2C#N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 2/20 0.45
▸ FYN P06241 1/20 0.41
▸ PARP1 P09874 4/20 0.40
▸ MAPK8 P45983 2/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39
▸ IKBKB O14920 1/20 0.39
▸ PDE1A P54750 1/20 0.39
▸ PDE1B Q01064 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ PDE7A Q13946 1/20 0.39
▸ PDE1C Q14123 1/20 0.39
▸ ABL1 P00519 1/20 0.38
▸ PRKD1 Q15139 2/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKD2 Q9BZL6 1/20 0.38
▸ MAP4K4 O95819 1/20 0.37
▸ CHUK O15111 1/20 0.37
▸ INSR P06213 1/20 0.37
▸ CAMKK2 Q96RR4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688149 0.90 TNKS2 (0.40) KISS1RIKBKBPRKD1EGLN1ALDH1A1
SCHEMBL32688014 0.86 ULK1 (0.38) KISS1RIKBKBPRKD1EGLN1ALDH1A1
SCHEMBL32688196 0.85 MAPK14 (0.38) PARP1MAPK14IKBKBALDH1A1HPGD
SCHEMBL32688247 0.84 ACMSD (0.44) IKBKBALDH1A1HPGDKMT2AADORA1
SCHEMBL32688271 0.84 ALDH1A1 (0.42) KISS1RALDH1A1HPGDKMT2A
SCHEMBL32688221 0.83 SIRT2 (0.46) KMT2A
SCHEMBL32688361 0.83 ALDH1A1 (0.41) IKBKBALDH1A1HPGDKMT2AADORA1
SCHEMBL32688016 0.81 KISS1R (0.42) KISS1RMAPK14ALDH1A1KMT2A
SCHEMBL32688038 0.81 ACMSD (0.45) ALDH1A1HPGDKMT2A
SCHEMBL32687986 0.79 KMT2A (0.39) ALDH1A1HPGDKMT2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KISS1R 3968/4885FYN 3662/4885PARP1 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback